Literature DB >> 31966617

Irisin attenuates H2O2-induced apoptosis in cardiomyocytes via microRNA-19b/AKT/mTOR signaling pathway.

Qing Peng1,2, Xiaojie Wang2, Kai Wu1, Kai Liu1, Si Wang1, Xiaoping Chen1.   

Abstract

Irisin, a novel muscle-secreted peptide, has been proposed to play a potential role in improving myocardial remodeling that leads to impaired myocardial function and heart failure. It has been reported that controlling reactive oxygen species (ROS) exposure could increase cardiomyocyte survival and prevent pathological remodeling of the myocardium. Therefore, we aimed to determine the potential protective effects of Irisin pretreatment against ROS in cardiomyocytes and explored the potential mechanisms. H9c2 cells that were subjected to H2O2 in vitro were used to mimic myocardial remodeling. Then, the effects of Irisin on myocardial cell proliferation, apoptosis and cellular ROS levels were evaluated during this process by using MTT assay, flow cytometry analysis and 2'7'-Dichloro fluoresc in diacetate (DCFH-DA). In order to determine whether Irisin could regulate any microRNA (miRNA) during this process, six miRNAs that are known to be involved in apoptosis of cardiomyocytes were assessed by qRT-PCR. The protective effects of Irisin on cardiomyocytes mediated by miR-19b were evaluated by detecting cell proliferation and apoptosis. In addition, the potential target of miR-19b was predicted with bioinformatics tools and verified using dual-luciferase reporter assay. Finally, the protein levels of members of the phosphatidylinositol 3-kinase (PI3K)/Akt/signaling pathway were also examined by Western Blot. Our study showed that Irisin treatment improved H2O2-induced cell viability and attenuated the levels of intracellular ROS and the apoptosis of cardiomyocytes in a dose-dependent manner. We also demonstrated that Irisin promoted cell viability and inhibited cell apoptosis via upregulating miR-19b expression. In addition, PTEN was identified as a functional target gene of miR-19b that was responsible for its anti-apoptotic effects in cardiomyocytes. Further study demonstrated that Irisin-regulated miR-19b could reactivate the AKT/mTOR signaling pathway blocked by H2O2 in H9c2 cells. We demonstrated that Irisin strongly enhances cellular proliferation and preventsapoptosis of cardiomyocytes as well as attenuates the levels of intracellular ROS induced by H2O2. These effects might be mediated through the miR-19b/AKT/mTOR signaling pathway, which provide a new insight into the mechanism by which Irisin may have beneficial effect on myocardial remodeling. IJCEP
Copyright © 2017.

Entities:  

Keywords:  AKT/mTOR signaling pathway; Cardiomyocytes; Irisin; apoptosis; microRNA-19b

Year:  2017        PMID: 31966617      PMCID: PMC6965300     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  6 in total

1.  Fndc5 knockdown significantly decreased the expression of neurotrophins and their respective receptors during neural differentiation of mouse embryonic stem cells.

Authors:  Reihane Ebadi; Farzaneh Rabiee; DorMohammad Kordi-Tamandani; Mohammad Hossein Nasr-Esfahani; Kamran Ghaedi
Journal:  Hum Cell       Date:  2021-03-08       Impact factor: 4.174

2.  Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus.

Authors:  Alexander A Berezin; Michael Lichtenauer; Elke Boxhammer; Ivan M Fushtey; Alexander E Berezin
Journal:  Front Physiol       Date:  2022-05-16       Impact factor: 4.755

Review 3.  Irisin: linking metabolism with heart failure.

Authors:  Jiamin Li; Susu Xie; Lei Guo; Jun Jiang; Han Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 4.  Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity.

Authors:  Nicola Marrano; Giuseppina Biondi; Anna Borrelli; Angelo Cignarelli; Sebastio Perrini; Luigi Laviola; Francesco Giorgino; Annalisa Natalicchio
Journal:  Biomolecules       Date:  2021-02-15

Review 5.  Effects of the FNDC5/Irisin on Elderly Dementia and Cognitive Impairment.

Authors:  Jin Peng; Jinhui Wu
Journal:  Front Aging Neurosci       Date:  2022-03-31       Impact factor: 5.750

Review 6.  The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease.

Authors:  Wen-Lu Ou-Yang; Bei Guo; Feng Xu; Xiao Lin; Fu-Xing-Zi Li; Su-Kang Shan; Feng Wu; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.